The trademark application Ambolipad was filed by TAIWAN LIPOSOME CO., LTD., a corporation established under the laws of Taiwan, Republic of China (the "Applicant"). The application was published for oppositions on June 8, 2023, and it was registered by office on September 15, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical and medicinal preparations and substances
Pharmaceutical products and formulations for the treatment of infections
Antibiotics
Antimicrobial preparations for inhibiting mold
Medicinal infusions for treating infectious diseases
Pharmaceutical preparations for treating skin disorders
Pharmaceutical preparations for the treatment of infectious diseases
Antibiotic ointments
Antifungal medications
Antifungal preparations
Pharmaceutical preparations for skin care
Bacterial poisons
Chemical preparations to treat mildew
Germicides
Liniments
Pharmaceutical preparation, namely a liposomal antifungal preparation